Lineage Cell Therapeutics Inc (LCTX) stock news · rev $14.6M
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
This LCTX news page leads with what Lineage Cell Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for LCTX yet. We will not pad this page with generic market recap.
Latest reported LCTX revenue for 2025-12-31 was $14.6M. Net income was -$63.5M. Revenue was up 53.2% from 2024-12-31 to 2025-12-31. LCTX currently screens at market cap $213.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LCTX stock page; for the tape open the quote page.
LCTX stock news FAQ
What are LCTX's latest revenue and net income?
Latest cached Lineage Cell Therapeutics Inc (LCTX) revenue for Dec 31, 2025 was $14.6M. Net income was -$63.5M. Statements: https://lician.com/financials/lctx
How did LCTX revenue change from the prior cached period?
Cached Lineage Cell Therapeutics Inc (LCTX) revenue was up 53.2% from $9.5M (Dec 31, 2024) to $14.6M (Dec 31, 2025). Statements: https://lician.com/financials/lctx
What is LCTX's market cap?
Lineage Cell Therapeutics Inc (LCTX) market cap is $213.6M on the latest cached fundamentals snapshot.
What kind of company is LCTX?
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Where is LCTX stock news listed?
Cached stock news for Lineage Cell Therapeutics Inc (LCTX) is listed at https://lician.com/news/lctx. Filings: https://lician.com/sec/lctx
Not investment advice.